Boston Scientific Corporation's Revenue by Segment
In fiscal year 2024, Boston Scientific Corporation's revenue by segment (products & services) are as follows:
- Cardiovascular: $10.76 B
- MedSurg: $5.99 B
Learn more about Boston Scientific Corporation’s Revenue by Geography
Check out competitors to Boston Scientific Corporation in a side-by-side comparison.
Explore additional financial metrics for Boston Scientific Corporation.
| Cardiovascular | 8161000000 |
|---|---|
| MedSurg | 5057000000 |
| Cardiovascular | 8819000000 |
|---|---|
| MedSurg | 5422000000 |
| Cardiovascular | 10755000000 |
|---|---|
| MedSurg | 5993000000 |
The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).
In fiscal year 2022, Boston Scientific Corporation's revenue by segment is as follows:
- Cardiovascular generated $8.16 B in revenue, representing 61.74% of its total revenue.
- MedSurg generated $5.06 B in revenue, representing 38.26% of its total revenue.
The biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 61.74% of its total revenue.
The smallest segment for Boston Scientific Corporation is the MedSurg, which represents 38.26% of its total revenue.
The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).
In fiscal year 2023, Boston Scientific Corporation's revenue by segment is as follows:
- Cardiovascular generated $8.82 B in revenue, representing 61.93% of its total revenue.
- MedSurg generated $5.42 B in revenue, representing 38.07% of its total revenue.
The biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 61.93% of its total revenue.
The smallest segment for Boston Scientific Corporation is the MedSurg, which represents 38.07% of its total revenue.
The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).
In fiscal year 2024, Boston Scientific Corporation's revenue by segment is as follows:
- Cardiovascular generated $10.76 B in revenue, representing 64.22% of its total revenue.
- MedSurg generated $5.99 B in revenue, representing 35.78% of its total revenue.
The biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 64.22% of its total revenue.
The smallest segment for Boston Scientific Corporation is the MedSurg, which represents 35.78% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2022 | 2023 | 2024 |
|---|---|---|---|
| Cardiovascular | 61.74% | 61.93% | 64.22% |
| MedSurg | 38.26% | 38.07% | 35.78% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of Boston Scientific Corporation.
In fiscal year 2024, the Cardiovascular generated the most revenue ($10.76 B), and the MedSurg generated the least revenue ($5.99 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
